Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Expression of IL-1α correlates with distant metastasis in patients with head and neck squamous cell carcinoma

  • León i Vintró, Xavier|||0000-0001-6286-630X
  • Bothe González, Carolina
  • García Lorenzo, Jacinto
  • Parreño, Matilde
  • Alcolea, Sonia
  • Quer, Miquel|||0000-0003-2563-6729
  • Vila Navarro, Luis
  • Camacho, Mercedes|||0000-0001-5970-3294
The presence of IL-1 in human cancers is associated with aggressive tumor biology but its prognostic value is unknown. We studied whether IL-1α expression is a prognostic marker of distant metastasis in patients with head and neck squamous cell carcinoma (HNSCC). IL-1α mRNA and protein levels were determined in tumor samples and cancer cell lines using RT-PCR and ELISA. The effects of constitutive IL-1α expression by tumor lines were characterized. IL-1α mRNA and protein secretion were higher in tumor samples from patients who later developed distant metastasis than in patients who did not. By using distant metastasis as a dependent variable, patients were classified into two categories of IL-1α transcript-levels. The high-IL-1α group had a significantly lower five-year distant metastasis-free survival than the low-IL-1α group [70.0% (CI 95%: 55.9-84.1%) vs 94.7% (CI 95%:90.2-99.2%)]. When IL-1α transcript-levels were combined with clinical factors related to tumor metastasis, the predictive power of the model increased significantly. Additionally, transcript levels of IL-1α correlated significantly with those of the IL-1 family genes and genes related to the metastatic process. IL-1 treatment of microvascular endothelial cells increased adhesion of HNSCC cells but no differences were found based on constitutive IL-1α expression by tumor cells. Nevertheless, IL-1α produced by tumor cells effectively increased their transmigration across the endothelium. We found a significant relationship between IL-1α expression and development of distant metastasis in HNSCC patients. IL-1α expression could help to define a subset of patients at high risk of distant metastasis who could benefit from adjuvant treatment.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe

  • Mena, Marisa|||0000-0003-2163-892X
  • Frias-Gomez, Jon|||0000-0002-0366-676X
  • Taberna, Miren|||0000-0002-2446-186X
  • Quirós, Beatriz|||0000-0002-6187-3732
  • Marquez, Sandra
  • Clavero, Omar|||0000-0001-9721-6382
  • Baena, Antoni.|||0000-0001-9221-8784
  • Lloveras, Belen|||0000-0001-8659-5241
  • Alejo, María
  • León i Vintró, Xavier|||0000-0001-6286-630X
  • García, Jacinto Montero
  • Mesia, Ricard|||0000-0002-3785-3563
  • Bermejo, Josep Oriol|||0000-0002-8581-9415
  • Bonfill Abella, Teresa|||0000-0003-2775-0293
  • Aguilà, Antón
  • Guix, Marta|||0000-0002-2143-0697
  • Hijano, Rafael|||0000-0001-6787-5440
  • Pavón, Miguel Ángel|||0000-0003-3677-5329
  • Torres, Montserrat A.
  • Tous, Sara|||0000-0002-5423-7092
  • Clèries, Ramon|||0000-0002-3637-4747
  • Alemany, Laia|||0000-0003-0945-6015
The incidence of human papillomavirus (HPV)-related oropharyngeal cancer is increasing in some regions. Nevertheless, the epidemiology of this disease has not been extensively investigated in southern Europe. We conducted a retrospective cohort study of patients diagnosed with primary oropharyngeal cancer from 1991 to 2016. Cancer tissues underwent histopathological evaluation, DNA quality control, HPV-DNA detection and p16 immunohistochemistry. Data were collected from medical records. Factors associated with HPV positivity and time trends were evaluated with multivariable Bayesian models. The adjusted prevalence of HPV-related cases in 864 patients with a valid HPV-DNA result was 9.7%, with HPV-DNA/p16 double positivity being considered. HPV-related oropharyngeal cancer was likely to occur in non-smokers and non-drinkers, to be located in the tonsil or diagnosed at advanced stages. Time-trend analysis showed an increasing risk of HPV-related oropharyngeal cancer in the most recent periods (5-year period increase of 30%). This increase was highest and with a clear increasing trend only in the most recent years (2012-2016). The prevalence of HPV-related oropharyngeal cancer started to sharply increase in the most recent years in our setting, as occurred two decades ago in areas where most oropharyngeal cancer cases are currently HPV-related. Our results provide a comprehensive assessment of the epidemiological landscape of HPV-related oropharyngeal cancer in a region of southern Europe.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

uPA/uPAR and SERPINE1 in head and neck cancer, Role in tumor resistance, metastasis, prognosis and therapy

  • Pavón, Miguel Angel
  • Arroyo Solera, Irene|||0000-0003-0425-1483
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • León i Vintró, Xavier|||0000-0001-6286-630X
  • Mangues, Ramon|||0000-0003-2661-9525
There is strong evidence supporting the role of the plasminogen activator system in head and neck squamous cell carcinoma (HNSCC), particularly of its uPA (urokinase plasminogen activator)/uPAR (urokinase plasminogen activator receptor) and SERPINE1 components. Overexpression of uPA/uPAR and SERPINE1 enhances tumor cell migration and invasion and plays a key role in metastasis development, conferring poor prognosis. The apparent paradox of uPA/uPAR and its inhibitor SERPINE1 producing similar effects is solved by the identification of SERPINE1 activated signaling pathways independent of uPA inhibition. Both uPA/uPAR and SERPINE1 are directly linked to the induction of epithelial-to-mesenchymal transition, the acquisition of stem cell properties and resistance to antitumor agents. The aim of this review is to provide insight on the deregulation of these proteins in all these processes. We also summarize their potential value as prognostic biomarkers or potential drug targets in HNSCC patients. Concomitant overexpression of uPA/uPAR and SERPINE1 is associated with a higher risk of metastasis and could be used to identify patients that would benefit from an adjuvant treatment. In the future, the specific inhibitors of uPA/uPAR and SERPINE1, which are still under development, could be used to design new therapeutic strategies in HNSCCs.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients

  • Pavón, Miguel Ángel|||0000-0003-3677-5329
  • Arroyo Solera, Irene|||0000-0003-0425-1483
  • Téllez Gabriel, Marta|||0000-0002-0895-2677
  • León i Vintró, Xavier|||0000-0001-6286-630X
  • Virós, David
  • López, Montserrat
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • López Pousa, Antonio|||0000-0003-1066-3951
  • Mangues, Ma Antonia|||0000-0002-1438-8515
  • Quer, Miquel|||0000-0003-2563-6729
  • Barnadas i Molins, Agustí|||0000-0002-0429-1349
  • Mangues, Ramon|||0000-0003-2661-9525
High SERPINE1 expression is a common event in head and neck squamous cell carcinoma (HNSCC); however, whether it plays a role in determining clinical outcome remains still unknown. We studied SERPINE1 as a prognostic marker in two HNSCC patient cohorts. In a retrospective study (n = 80), high expression of SERPINE1 was associated with poor progression-free (p = 0.022) and cancer-specific (p = 0.040) survival. In a prospective study (n = 190), high SERPINE1 expression was associated with poor local recurrence-free (p = 0.022), progression-free (p = 0.002) and cancer-specific (p = 0.006) survival. SERPINE1 expression was identified as an independent risk factor for progression-free survival in patients treated with chemo-radiotherapy or radiotherapy (p = 0.043). In both patient cohorts, high SERPINE1 expression increased the risk of metastasis spread (p = 0.045; p = 0.029). The association between SERPINE1 expression and survival was confirmed using the HNSCC cohort included in The Cancer Genome Atlas project (n = 507). Once again, patients showing high expression had a poorer survival (p < 0.001). SERPINE1 over-expression in HNSCC cells reduced cell proliferation and enhanced migration. It also protected cells from cisplatin-induced apoptosis, which was accompanied by PI3K/AKT pathway activation. Downregulation of SERPINE1 expression had the opposite effect. We propose SERPINE1 expression as a prognostic marker that could be used to stratify HNSCC patients according to their risk of recurrence.